COMMUNIQUÉS West-GlobeNewswire

Tabula Rasa HealthCare Participates in NPA’s Spring Policy Forum
03/04/2019
Hosts Reception, Exhibits Technology and Services, and Introduces New Product for PACE MOORESTOWN, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC) , a healthcare technology [...]
Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019
03/04/2019
Highlighting Important Cancer Gene, STAT3, Therapeutic Strategy in Pancreatic, Non-Small Cell Lung Cancers and Acute Myelogenous Leukemia HOUSTON, April 03, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: [...]
Precipio’s HemeScreen™ Adopted by Methodist Health
03/04/2019
New Molecular Screening Assay Technology Gains Traction NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that Methodist Hospital , [...]
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
03/04/2019
Company Announcement Phase III study to examine daratumumab plus lenalidomide as maintenance treatment in patients with newly diagnosed multiple myeloma Study utilizes the subcutaneous formulation of daratumumab Study [...]
RTI Surgical® Showcases Novel Spine Portfolio at ISASS19
03/04/2019
RTI to host Lunch Workshop as the Platinum Partner at ISASS19 and highlight recent additions to its Spine portfolio, including the coflex® Interlaminar Stabilization® device DEERFIELD, Ill., April 03, 2019 (GLOBE [...]
T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
LEXINGTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]
Metacrine to Present Phase 1 Results of MET409, an Optimized Next Generation FXR Agonist at The International Liver Congress (EASL) 2019
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Data in Parkinson’s Disease Model in Non-human Primates Demonstrate Reversal of Cognitive Deficits with Novel NMDA Receptor Modulator, NYX-458
03/04/2019
EVANSTON, Ill., April 03, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
03/04/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae Data to be Presented in Oral Session at ECCMID 2019 Oxford, UK, and [...]
XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. [...]
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms
03/04/2019
– Collaboration enables BlueRock to discover and develop engineered cell medicines broadly across neurology, cardiology and immunology – – Collaboration enables Editas Medicine to discover and develop engineered cell [...]
Sunesis Pharmaceuticals to Present at 18th Annual Needham & Company Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate [...]
Emerald Health Therapeutics Signs Letter of Intent to Supply Cannabis to Québec Market
03/04/2019
VANCOUVER, British Columbia, April 03, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has signed a letter of intent to supply cannabis to the Société Québécoise du [...]
Rockwell Medical, Inc. to Present at H.C Wainwright Global Life Sciences Conference
03/04/2019
WIXOM, Mich., April 03, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the H.C Wainwright [...]
MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million
03/04/2019
TORONTO, April 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Dr. Charles Brenner, Discoverer of Nutrient Nicotinamide Riboside as a Vitamin, Announced as Speaker at Upgrade XP’s Sixth Annual Biohacking Conference
03/04/2019
World’s leading expert on NAD metabolism to speak at #UpgradeXP2019 LOS ANGELES, April 03, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its Chief Scientific Advisor, Dr. Charles Brenner, the [...]
Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy
03/04/2019
- Enrolled 23 patients in ACH-4471 Phase 2 C3G six and 12-month clinical trials - - Targeting end-of-Phase 2 meeting with FDA in fourth quarter of 2019 - BLUE BELL, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Achillion [...]
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019
03/04/2019
Company Release no. 06/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 April 2019 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019 Summary: At Veloxis Pharmaceuticals A/S’ Annual General [...]
Short report of the status of the review in Oasmia
03/04/2019
Two weeks ago, March 19 th , the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The new Board has since then taken control over the Company and started implementing new [...]

Pages